Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC727992 Inhibitors

Wortmannin and LY294002 are inhibitors of PI3K, an enzyme involved in the PI3K/AKT signaling pathway that is fundamental for many cellular processes, including growth, proliferation, and survival. By inhibiting PI3K, these chemicals can affect proteins regulated by this pathway. Rapamycin specifically inhibits mTOR, a central protein in the cellular growth and nutrient sensing pathway, influencing proteins that are controlled by mTOR signaling. SP600125 and SB203580 target the stress-activated JNK and p38 MAP kinase respectively, which are pathways involved in inflammation, apoptosis, and cell differentiation. Inhibition of these kinases can lead to changes in the regulation of proteins associated with these pathways. ZM-447439 disrupts the function of Aurora kinases, which play a key role in cell division, thus potentially affecting proteins involved in mitosis.

Trichostatin A and PD0332991 act on epigenetic and cell cycle regulators, respectively. Trichostatin A changes gene expression by inhibiting histone deacetylases, while PD0332991 targets CDK4/6 to halt the cell cycle. U0126 prevents the activation of the MEK1/2, thereby influencing the MAPK/ERK signaling cascade. Ibrutinib, Olaparib, and ABT-199 inhibit Bruton's tyrosine kinase, PARP, and Bcl-2, respectively. Each of these enzymes is involved in crucial cellular pathways: Ibrutinib affects B cell receptor signaling, Olaparib hinders DNA repair, and Venetoclax induces apoptosis, each altering the regulation and function of proteins associated with their respective pathways.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

An inhibitor of phosphoinositide 3-kinases (PI3K), which can affect proteins regulated by the PI3K/Akt pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor, which can affect protein synthesis and cell growth, potentially influencing proteins that are downstream of mTOR signaling.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of c-Jun N-terminal kinase (JNK), which can alter apoptosis and other cellular processes, potentially affecting proteins regulated by JNK signaling.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$153.00
$356.00
15
(1)

An Aurora kinase inhibitor, which can disrupt cell division and therefore potentially affect proteins that are involved in the cell cycle.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

A histone deacetylase inhibitor, which can change gene expression patterns and potentially affect proteins regulated by chromatin remodeling.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

A cyclin-dependent kinase inhibitor (CDK4/6), which can halt cell cycle progression, potentially influencing proteins involved in cell cycle regulation.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

A p38 MAP kinase inhibitor, which can modulate inflammatory responses and cell differentiation, potentially affecting proteins in the p38 MAPK pathway.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

An inhibitor of MEK1/2, which can prevent the activation of MAPK/ERK pathway, potentially impacting proteins downstream of this signaling cascade.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Another PI3K inhibitor that can suppress the PI3K/AKT signaling pathway, potentially influencing proteins involved in survival and metabolism.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

A Bruton's tyrosine kinase inhibitor, which can affect B cell receptor signaling, potentially impacting proteins involved in this pathway.